Cargando…

Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases

Okur-Chung Neurodevelopmental Syndrome (OCNDS) and Poirier-Bienvenu Neurodevelopmental Syndrome (POBINDS) were recently identified as rare neurodevelopmental disorders. OCNDS and POBINDS are associated with heterozygous mutations in the CSNK2A1 and CSNK2B genes which encode CK2α, a serine/threonine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unni, Prasida, Friend, Jack, Weinberg, Janice, Okur, Volkan, Hochscherf, Jennifer, Dominguez, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608649/ https://www.ncbi.nlm.nih.gov/pubmed/36310603 http://dx.doi.org/10.3389/fmolb.2022.851547

Ejemplares similares

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics
por: Gyenis, Laszlo, et al.
Publicado: (2022)

CSNK2 in cancer: pathophysiology and translational applications
por: Strum, Scott W., et al.
Publicado: (2021)

De Novo CSNK2B Mutations in Five Cases of Poirier–Bienvenu Neurodevelopmental Syndrome
por: Yang, Qi, et al.
Publicado: (2022)

Germline de novo variants in CSNK2B in Chinese patients with epilepsy
por: Li, Jinliang, et al.
Publicado: (2019)

Targeting Csnk1a1 in leukemia
por: Stegmaier, Kimberly
Publicado: (2014)

Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2α(Lys198Arg)
por: Werner, Christian, et al.
Publicado: (2022)

Splicing Interruption by Intron Variants in CSNK2B Causes Poirier–Bienvenu Neurodevelopmental Syndrome: A Focus on Genotype–Phenotype Correlations
por: Zhang, Wen, et al.
Publicado: (2022)

CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling
por: Matsumoto, Moe, et al.
Publicado: (2023)

Two different presentations of de novo variants of CSNK2B: two case reports
por: Wilke, Matheus V. M. B, et al.
Publicado: (2022)

Prognostic value and immunological role of CSNK1D in human cancers
por: Wang, Jianguo, et al.
Publicado: (2023)

Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome—Two Sides of the Same Coin?
por: Ballardin, Demetra, et al.
Publicado: (2022)

De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway
por: Asif, Maria, et al.
Publicado: (2022)

Identification of novel CSNK2A1 variants and the genotype–phenotype relationship in patients with Okur–Chung neurodevelopmental syndrome: a case report and systematic literature review
por: Wu, Ruo-hao, et al.
Publicado: (2021)

CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling
por: Yu, Shijun, et al.
Publicado: (2021)

Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses
por: Yang, Xuan, et al.
Publicado: (2022)

Long noncoding RNA HIKER regulates erythropoiesis in Monge’s disease via CSNK2B
por: Azad, Priti, et al.
Publicado: (2023)

CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer
por: Shi, Zhan, et al.
Publicado: (2021)

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
por: Yang, Cui-Ping, et al.
Publicado: (2018)

Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022)

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2
por: Yang, Xuan, et al.
Publicado: (2022)

Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma
por: Liu, Guanzheng, et al.
Publicado: (2021)

Compartmentalization of casein kinase 1 γ CSNK1G controls the intracellular trafficking of ceramide
por: Goto, Asako, et al.
Publicado: (2022)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

Knockdown of CSNK2ß suppresses MDA-MB231 cell growth, induces apoptosis, inhibits migration and invasion
por: Karna, Shibendra Kumar Lal, et al.
Publicado: (2020)

Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia
por: Xu, Xiaoyu, et al.
Publicado: (2021)

CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression
por: Yang, Bing, et al.
Publicado: (2023)

lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level
por: Nie, Zhenlin, et al.
Publicado: (2023)

CSNK1E/CTNNB1 Are Synthetic Lethal To TP53 in Colorectal Cancer and Are Markers for Prognosis
por: Tiong, Khong-Loon, et al.
Publicado: (2014)

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
por: Bello, Erica, et al.
Publicado: (2015)

Author Correction: Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
por: Yang, Cui-Ping, et al.
Publicado: (2018)

Huaier Suppresses Breast Cancer Progression via linc00339/miR-4656/CSNK2B Signaling Pathway
por: Wang, Wei, et al.
Publicado: (2019)

Circular RNA CSNK1G1 promotes the progression of osteoarthritis by targeting the miR-4428/FUT2 axis
por: Xiao, Jianwei, et al.
Publicado: (2021)

Circular RNA CSNK1G1 promotes the progression of osteoarthritis by targeting the miR-4428/FUT2 axis
por: Xiao, Jianwei, et al.
Publicado: (2022)

MicroRNA-1205 Suppresses Hepatocellular Carcinoma Cell Proliferation via a CSNK2B/CDK4 Axis
por: Li, Xiang, et al.
Publicado: (2023)

Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
por: Järås, Marcus, et al.
Publicado: (2014)

PS162. Genetic role of CSNK1E on circadian and childhood characteristics of the patients with major depressive disorder
por: Joo, Eun-Jeong, et al.
Publicado: (2016)

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
por: Jiang, Chao, et al.
Publicado: (2019)

Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression
por: Yu, Shijun, et al.
Publicado: (2021)

Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders
por: Di Stazio, Mariateresa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0vc6mfnmamog7dfbjuhpcfds1c